Legacy Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$356K Buy
710
+75
+12% +$36K 0.03% 220
2026
Q1
$312K Sell
635
-67
-10% -$36.4K 0.04% 208
2025
Q4
$407K Buy
+702
New +$397K 0.04% 188
2025
Q2
Sell
-3,002
Closed -$1.5M 365
2025
Q1
$1.5M Buy
3,002
+172
+6% +$93.2K 0.15% 113
2024
Q4
$1.47M Sell
2,830
-112
-4% -$61.6K 0.14% 108
2024
Q3
$1.82M Buy
2,942
+88
+3% +$52.1K 0.2% 91
2024
Q2
$1.58M Sell
2,854
-28
-1% -$16K 0.19% 90
2024
Q1
$1.68M Sell
2,882
-1,654
-36% -$928K 0.21% 86
2023
Q4
$2.41M Sell
4,536
-1,673
-27% -$810K 0.31% 69
2023
Q3
$3.15M Sell
6,209
-160
-3% -$85.3K 0.51% 48
2023
Q2
$3.32M Sell
6,369
-176
-3% -$95K 0.49% 43
2023
Q1
$3.77M Buy
6,545
+318
+5% +$179K 0.7% 33
2022
Q4
$3.43M Buy
6,227
+1,159
+23% +$614K 0.63% 33
2022
Q3
$2.57M Buy
5,068
+668
+15% +$374K 0.57% 35
2022
Q2
$2.39M Buy
4,400
+682
+18% +$375K 0.5% 37
2022
Q1
$2.2M Buy
+3,718
New +$2.14M 0.43% 42
2019
Q2
Sell
-47
Closed -$13K 415
2019
Q1
$13K Buy
+47
New +$11.7K ﹤0.01% 314
2018
Q4
Sell
-47
Closed -$11K 365
2018
Q3
$11K Hold
47
0.01% 342
2018
Q2
$10K Hold
47
0.01% 307
2018
Q1
$10K Hold
47
0.01% 270
2017
Q4
$8K Sell
47
-21
-31% -$4.02K 0.01% 275
2017
Q3
$12K Buy
+68
New +$12.3K 0.01% 203

Other funds holding TMO

Legacy Advisors's TMO Position: Q2 2026 in Review

Legacy Advisors increased its Thermo Fisher Scientific (TMO) stake by 12% in Q2 2026, buying an estimated $36K and bringing the position to 710 shares worth $356K. The position accounts for 0.03% of the portfolio, ranked #220.

Legacy Advisors first reported a position in TMO in Q3 2017 and has held it in 22 quarters since. The position peaked at $3.77M in Q1 2023. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Legacy Advisors held 710 shares of Thermo Fisher Scientific worth $356K as of Q2 2026.
  • Legacy Advisors bought 75 Thermo Fisher Scientific shares in Q2 2026, an estimated $36K.
  • Thermo Fisher Scientific made up 0.03% of Legacy Advisors's portfolio in Q2 2026, its #220 holding.
  • Legacy Advisors first reported a position in Thermo Fisher Scientific in Q3 2017 and has held it in 22 quarters since.
  • Legacy Advisors's Thermo Fisher Scientific position peaked at $3.77M in Q1 2023.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Legacy Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.